Stenabolic

pharmacological · endocrine · musculoskeletal · Oral

Stenabolic. REV-ERB-α agonist — circadian-rhythm transcription factor activator that increases mitochondrial biogenesis + glucose oxidation in… Oral half-life 4 h.

REV-ERB-α agonist — circadian-rhythm transcription factor activator that increases mitochondrial biogenesis + glucose oxidation in muscle. Marketed in research-chem space as "exercise mimetic"; oral bioavailability poor (<1% in rodents). Banned by WADA.